| Rotavirus vaccines in Belgium: policy and impact T Braeckman, K Van Herck, M Raes, A Vergison, M Sabbe, P Van Damme The Pediatric infectious disease journal 30 (1), S21-S24, 2011 | 112 | 2011 |
| Measles outbreak in Europe: susceptibility of infants too young to be immunized E Leuridan, M Sabbe, P Van Damme Vaccine 30 (41), 5905-5913, 2012 | 80 | 2012 |
| Ongoing measles outbreak in Wallonia, Belgium, December 2016 to March 2017: characteristics and challenges T Grammens, C Schirvel, S Leenen, N Shodu, V Hutse, EM da Costa, ... Eurosurveillance 22 (17), 30524, 2017 | 79 | 2017 |
| Impact of rotavirus vaccination on laboratory confirmed cases in Belgium G Hanquet, G Ducoffre, A Vergison, P Neels, M Sabbe, P Van Damme, ... Vaccine 29 (29-30), 4698-4703, 2011 | 74 | 2011 |
| Risk factors for death from invasive pneumococcal disease, Europe, 2010 A Navarro-Torné, JG Dias, F Hruba, PL Lopalco, L Pastore-Celentano, ... Emerging infectious diseases 21 (3), 417, 2015 | 73 | 2015 |
| Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014 M Sabbe, N Berger, A Blommaert, B Ogunjimi, T Grammens, M Callens, ... Eurosurveillance 21 (27), 30273, 2016 | 65 | 2016 |
| Varicella paediatric hospitalisations in Belgium: a 1-year national survey S Blumental, M Sabbe, P Lepage Archives of Disease in Childhood 101 (1), 16-22, 2016 | 56 | 2016 |
| Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges G Hanquet, T Lernout, A Vergison, J Verhaegen, E Kissling, D Tuerlinckx, ... Vaccine 29 (16), 2856-2864, 2011 | 56 | 2011 |
| Survey of non-invasive ventilation for acute exacerbation of chronic obstructive pulmonary disease patients in emergency departments in Belgium D Vanpee, L Delaunois, P Lheureux, F Thys, M Sabbe, A Meulemans, ... European Journal of Emergency Medicine 9 (3), 217-224, 2002 | 53 | 2002 |
| The resurgence of mumps and pertussis M Sabbe, C Vandermeulen Human vaccines & immunotherapeutics 12 (4), 955-959, 2016 | 47 | 2016 |
| Viral aetiology of influenza-like illness in Belgium during the influenza A (H1N1) 2009 pandemic A Hombrouck, M Sabbe, V Van Casteren, F Wuillaume, D Hue, ... European Journal of Clinical Microbiology & Infectious Diseases 31, 999-1007, 2012 | 36 | 2012 |
| Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008 C Simoens, M Sabbe, P Van Damme, P Beutels, M Arbyn Eurosurveillance 14 (46), 19407, 2009 | 30 | 2009 |
| Different measles outbreaks in Belgium, January to June 2016–a challenge for public health T Grammens, V Maes, V Hutse, V Laisnez, C Schirvel, JM Trémérie, ... Eurosurveillance 21 (32), 30313, 2016 | 27 | 2016 |
| Obstacles in measles elimination: an in-depth description of a measles outbreak in Ghent, Belgium, spring 2011 T Braeye, M Sabbe, V Hutse, W Flipse, L Godderis, G Top Archives of Public Health 71, 1-7, 2013 | 26 | 2013 |
| Measles resurgence in Belgium from January to mid-April 2011: a preliminary report M Sabbe, D Hue, V Hutse, P Goubau Eurosurveillance 16 (16), 19848, 2011 | 21 | 2011 |
| Cost-effectiveness of 10-and 13-valent pneumococcal conjugate vaccines in childhood P Beutels, A Blommaert, G Hanquet, J Bilcke, N Thiry, M Sabbe, ... | 18 | 2011 |
| Performance of acute flaccid paralysis surveillance compared with W orld H ealth O rganization standards S Desai, T Smith, BR Thorley, D Grenier, N Dickson, E Altpeter, ... Journal of paediatrics and child health 51 (2), 209-214, 2015 | 16 | 2015 |
| Cohort event monitoring of adverse reactions to COVID-19 vaccines in seven European Countries: pooled results on first dose M Raethke, F van Hunsel, NH Thurin, C Dureau-Pournin, D Mentzer, ... Drug Safety 46 (4), 391-404, 2023 | 14 | 2023 |
| Haemolytic uremic syndrome surveillance in children less than 15 years in Belgium, 2009–2015 S Jacquinet, K De Rauw, D Pierard, N Godefroid, L Collard, K Van Hoeck, ... Archives of Public Health 76, 1-7, 2018 | 13 | 2018 |
| Inferring rubella outbreak risk from seroprevalence data in Belgium S Abrams, E Kourkouni, M Sabbe, P Beutels, N Hens Vaccine 34 (50), 6187-6192, 2016 | 13 | 2016 |
